Pippa S. Loupe
- Psychiatry and Mental health top 2%
- Migraine and Headache Studies 7
- Attention Deficit Hyperactivity Disorder 3
-
- Trigeminal Neuralgia and Treatments 5
- Physiology top 10%
- Pharmaceutical Science top 10%
- Chemical Reactions and Isotopes 4
- Neurology top 10%
-
- Pharmaceutical studies and practices 5
-
- Pharmacogenetics and Drug Metabolism 4
-
- Genetic Neurodegenerative Diseases 4
-
- Ion channel regulation and function 3
- Co-authors
- Marcelo E. BigalYuju MaRichard B. LiptonAlan M. RapoportStephen D. SilbersteinRonghua YangDavid W. DodickRami Burstein
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Pippa S. Loupe
34 papers receiving 881 citations
Peers
Comparison fields: 5 of 91
- Psychiatry and Mental health 642
- Pathology and Forensic Medicine 473
- Physiology 259
- Pharmaceutical Science 51
- Neurology 68
Countries citing papers authored by Pippa S. Loupe
This map shows the geographic impact of Pippa S. Loupe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pippa S. Loupe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pippa S. Loupe more than expected).
Fields of papers citing papers by Pippa S. Loupe
This network shows the impact of papers produced by Pippa S. Loupe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pippa S. Loupe. The network helps show where Pippa S. Loupe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pippa S. Loupe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 5 | |
| 5 | 2019 | 7 | |
| 6 | 2019 | 24 | |
| 7 | 2018 | 31 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 24 | |
| 10 | 2018 | 27 | |
| 11 | 2016 | 20 | |
| 12 | 2016 | 32 | |
| 13 | 2015 | 205 | |
| 14 | 2015 | 226 | |
| 15 | 2014 | 2 | |
| 16 | 2002 | 4 | |
| 17 | 1998 | 18 | |
| 18 | 1997 | 1 | |
| 19 | 1995 | 10 | |
| 20 | 1995 | 7 |
About Pippa S. Loupe
Pippa S. Loupe is a scholar working on Psychiatry and Mental health, Pharmaceutical Science and Pharmacology, having authored 34 papers that have together received 919 indexed citations. Recurring topics across this work include Migraine and Headache Studies (7 papers), Pharmaceutical studies and practices (5 papers), Trigeminal Neuralgia and Treatments (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Genetic Neurodegenerative Diseases (4 papers), Chemical Reactions and Isotopes (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Psychiatry and Mental health (642 citations), Pathology and Forensic Medicine (473 citations) and Physiology (259 citations). Pippa S. Loupe has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Marcelo E. Bigal, Yuju Ma, Richard B. Lipton, Alan M. Rapoport, Stephen D. Silberstein, Ronghua Yang, David W. Dodick, Rami Burstein, Lawrence C. Newman and Ernesto Aycardi. Their work appears in journals such as Neurology, The Lancet Neurology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.